EUVIMEDEUVIMED entdecken
Crossref

A biomimetic miniaturized in vitro model to target early markers of neonatal pulmonary vascular injury

Motaharehsadat Heydarian iD, Ali Doryab iD, Juan Henao iD, Benjamin Schubert iD, Otmar Schmid iD, Anne Hilgendorff iD

American Journal of Physiology-Lung Cellular and Molecular Physiology · 01.07.2026 · 331 (1) · L92-L104

DOI: 10.1152/ajplung.00002.2026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Lung Cellular and Molecular Physiology, erschienen am 01.07.2026. Verfasst von Motaharehsadat Heydarian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Lung Health and Immunity and Comprehensive Pneumology Center, Helmholtz Zentrum München, Munich, Germany. Hauptthemen laut MEDLINE: Biomimetics, Pulmonary Artery, Bronchopulmonary Dysplasia, Lung. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft (DFG).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We present a biomimetic, miniaturized in vitro model that replicates key features of neonatal pulmonary vascular injury. By integrating physiologically relevant cues, this platform enables early detection of injury-associated molecular markers and mechanistic interrogation of disease onset. This scalable model offers a powerful tool for studying neonatal lung vascular pathology and for accelerating the discovery of early diagnostic and therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomimeticsPulmonary ArteryBronchopulmonary DysplasiaLungHumansEndothelial CellsInfant, NewbornBiomarkersMyocytes, Smooth MuscleCoculture TechniquesOxygenMicrophysiological SystemsMonocytes

Stichwörter der Autor:innen

biomimetic in vitro perfusion modelbronchopulmonary dysplasiapulmonary vascular diseaseshear stressvascular injury

Substanzen

BiomarkersOxygen

Autor:innen und Institutionen

  • Institute for Lung Health and Immunity and Comprehensive Pneumology Center, Helmholtz Zentrum München, Munich, Germany.
  • Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.
  • Institute for Computational Biology, Helmholtz Zentrum München, Munich, Germany.
  • Dr. von Hauner Children's Hospital, University Hospital Ludwig-Maximilian University, Munich, Germany.
  • Section of Neonatology, Pediatric Intensive Care, Pediatric Cardiology, Department of Paediatrics, School of Medicine and Health Sciences, Pediatric Pneumology and Allergology, and Research Centre Neurosensory Science,…

ORCID-Profile: Motaharehsadat Heydarian, Ali Doryab, Juan Henao, Benjamin Schubert, Otmar Schmid, Anne Hilgendorff

Förderung

  • Deutsche Forschungsgemeinschaft (DFG)

Zitieren

APA

Heydarian, M., Doryab, A., Henao, J., Schubert, B., Schmid, O., & Hilgendorff, A. (2026). A biomimetic miniaturized in vitro model to target early markers of neonatal pulmonary vascular injury. American Journal of Physiology-Lung Cellular and Molecular Physiology, 331(1), L92-L104. https://doi.org/10.1152/ajplung.00002.2026

Vancouver

Heydarian M, Doryab A, Henao J, Schubert B, Schmid O, Hilgendorff A. A biomimetic miniaturized in vitro model to target early markers of neonatal pulmonary vascular injury. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2026;331(1):L92-L104. doi:10.1152/ajplung.00002.2026

BibTeX
@article{Heydarian2026,
  author = {Heydarian, Motaharehsadat and Doryab, Ali and Henao, Juan and Schubert, Benjamin and Schmid, Otmar and Hilgendorff, Anne},
  title = {A biomimetic miniaturized in vitro model to target early markers of neonatal pulmonary vascular injury},
  journal = {American Journal of Physiology-Lung Cellular and Molecular Physiology},
  year = {2026},
  volume = {331},
  number = {1},
  pages = {L92--L104},
  doi = {10.1152/ajplung.00002.2026}
}
Kostenlos starten →